Theramex
Theramex is a global specialty pharmaceutical company dedicated to supporting women's health through every stage of life. With over 500 employees across more than 80 countries and more than 20 products, they aim to improve the lives of women worldwide by providing patient-focused, effective solutions. Their mission is to be the leading global company in women's health care, offering innovative and effective solutions that support women at every stage of their lives. The company fosters a unique culture based on core values of Passion, Integrity, Collaboration, and Agility, emphasizing a dynamic, inclusive, and innovative work environment. Theramex is committed to making a difference in women's health, supporting communities through events and initiatives, and empowering its dedicated team to excel and grow.
Industries
Nr. of Employees
large (251-1000)
Theramex
50 Broadway, London, SW1H 0BL, United Kingdom
Patents
Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-11833244-B2
View DetailsBioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-11185496-B2
View DetailsBioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-10188602-B2
View Details
Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-11833244-B2
View DetailsBioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-11185496-B2
View DetailsBioerodible implant for long-term drug delivery and associated methods of manufacture and use
US-10188602-B2
View DetailsProducts
Risedronate sodium — oral bisphosphonate (osteoporosis)
Oral bisphosphonate indicated for treatment of osteoporosis and reduction of fracture risk.
Gastro-resistant risedronate formulation (oral)
Gastro-resistant oral formulation of risedronate intended to improve gastric tolerability for osteoporosis therapy.
Promestriene topical vaginal preparation
Topical vaginal estrogenic preparation used for local genitourinary symptoms associated with menopause.
Topical estradiol gel (menopausal symptom management)
Topical estradiol formulation indicated for management of menopausal symptoms.
Combined oral contraceptive (nomegestrol acetate / estradiol)
Oral combined hormonal contraceptive containing a progestogen and estradiol indicated for contraception.
Transdermal estradiol patch (menopausal hormone therapy)
Transdermal estradiol patch available in multiple regimens for menopausal hormone therapy.
Risedronate sodium — oral bisphosphonate (osteoporosis)
Oral bisphosphonate indicated for treatment of osteoporosis and reduction of fracture risk.
Gastro-resistant risedronate formulation (oral)
Gastro-resistant oral formulation of risedronate intended to improve gastric tolerability for osteoporosis therapy.
Promestriene topical vaginal preparation
Topical vaginal estrogenic preparation used for local genitourinary symptoms associated with menopause.
Topical estradiol gel (menopausal symptom management)
Topical estradiol formulation indicated for management of menopausal symptoms.
Combined oral contraceptive (nomegestrol acetate / estradiol)
Oral combined hormonal contraceptive containing a progestogen and estradiol indicated for contraception.
Transdermal estradiol patch (menopausal hormone therapy)
Transdermal estradiol patch available in multiple regimens for menopausal hormone therapy.
Services
Assessment and execution of licensing deals and distributor partnerships to expand therapeutic portfolios and enter new markets.
Regional medinfo and customer service contacts for medical enquiries, intake of adverse event reports and product quality complaints.
Collection, investigation and regulatory reporting of safety data for marketed and developmental products using internal safety teams and reporting systems.
Creation and dissemination of patient-facing and prescriber educational resources and direct healthcare professional communications for safety and prescribing guidance.
Management of affiliate operations, local customer service and distributor networks to support product launches and supply continuity across multiple countries.
Assessment and execution of licensing deals and distributor partnerships to expand therapeutic portfolios and enter new markets.
Regional medinfo and customer service contacts for medical enquiries, intake of adverse event reports and product quality complaints.
Collection, investigation and regulatory reporting of safety data for marketed and developmental products using internal safety teams and reporting systems.
Creation and dissemination of patient-facing and prescriber educational resources and direct healthcare professional communications for safety and prescribing guidance.
Management of affiliate operations, local customer service and distributor networks to support product launches and supply continuity across multiple countries.
Expertise Areas
- Women's health therapeutics (contraception, menopause, osteoporosis, fertility)
- Pharmacovigilance and drug safety
- Medical information and medical affairs
- Regulatory affairs (EU/EMA)
Key Technologies
- Pharmacovigilance systems and adverse event monitoring
- Regional medical information helplines and contact centres
- Regulatory submission workflows for EMA/EU approvals
- Development and distribution of HCP/patient educational materials and DHPCs
News & Updates
Celebrating International Women's Day.
Supporting World Menopause Day.
Distribution agreement in Ireland and Nordic markets.
Appointment of Robert Stewart as CEO.
Acquisition of rights for Zoely contraceptive.
Funding reproductive medicine research.
Celebrating International Women's Day.
Supporting World Menopause Day.
Distribution agreement in Ireland and Nordic markets.
Appointment of Robert Stewart as CEO.
Acquisition of rights for Zoely contraceptive.
Funding reproductive medicine research.